Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks – Yahoo Finance
- Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks Yahoo Finance
- Eli Lilly Tumbles On Lowered Guidance As Weight-Loss Drug Sales Slow Investor’s Business Daily
- Eli Lilly misses 2024 revenue numbers, but GLP-1 pill may help Yahoo Finance
- Eli Lilly’s stock falls as weight-loss drug sales disappoint MarketWatch
- Lilly forecasts weak fourth-quarter sales of weight-loss drug, shares slump Reuters
Source: Air Tools